LVsh5/C46-modified PBMCs inhibit infection from laboratory and clinical strains of HIV-1. (a, b) PBMCs were transduced with the LVsh5/C46 (sh5/C46), C46 alone, sh5/GFP, or GFP vectors, at MOIs of 0.5, and 4 days later, transduction efficiency was determined by flow cytometry, (a) measuring CCR5 and C46 expression, or CCR5 and enhanced green fluorescent protein. (b) Cells were then infected with R5-tropic strain NFNSX or X4-tropic NL4-3, at MOIs of 0.02, and p24 protein levels was measured to assess HIV-1 replication. (c) PBMCs were transduced with LVsh5/C46 (sh5/C46) at MOI of five in four independent experiments, and 48 hours later were challenged with the HIV-1 laboratory strains BaL (R5-), SF162 (R5-), or Bru (X4-tropic) at MOIs of 0.14, 0.16, and 0.17, respectively. Four days postinfection, p24 levels were assessed and plotted relative to untransduced cells (this was done due to high variability between experiments and donor variability). Average p24 readings were: untransduced-BaL: 134,935 ng/ml (SE: 80,245)/transduced-BaL: 24,159 ng/ml (SE: 5,665). Untransduced-SF162: 72,153 ng/ml (SE: 30,041)/transduced-SF162: 20,121 ng/ml (SE: 6,181). Untransduced-Bru: 106,066 ng/ml (SE: 39,585)/transduced-Bru: 19,371 ng/ml (SE: 5,033). (d) PBMCs were transduced with LVsh5/C46 (sh5/C46) at MOI of 5, and 48 hours later were challenged with the HIV-1 clinical isolates 92US723 (R5/X4-tropic, Clade B) or 92UG021(X4-tropic, Clade D) in three independent experiments. Viral infection levels were determined relative to untransduced cells. Average p24 levels were: untransduced-92US723: 94,986 ng/ml (SE: 60,533)/transduced-92US723: 20,148 ng/ml (SE: 15,764). Untransduced-92UG021: 45,804 ng/ml (SE: 16,988)/transduced-92UG021: 15,536 ng/ml (SE: 9,401). GFP, green fluorescent protein; MOI, multiplicity of infection; PBMC, peripheral blood mononuclear cell.